Page last updated: 2024-09-04

levofloxacin and Genito-urinary Cancer

levofloxacin has been researched along with Genito-urinary Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Adamowicz, J; Dąbrowski, P; Drewa, T; Fekner, Z; Kloskowski, T; Pokrywczyńska, M; Rasmus, M; Siedlecka, N; Szeliski, K; Wolska, A	1

Other Studies

1 other study(ies) available for levofloxacin and Genito-urinary Cancer

Article	Year
Ciprofloxacin and Levofloxacin as Potential Drugs in Genitourinary Cancer Treatment-The Effect of Dose-Response on 2D and 3D Cell Cultures. International journal of molecular sciences, 2021, Nov-04, Volume: 22, Issue:21 Topics: Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Cell Culture Techniques, Three Dimensional; Cell Cycle; Cell Proliferation; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Levofloxacin; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Urogenital Neoplasms	2021

Article

Year

Ciprofloxacin and Levofloxacin as Potential Drugs in Genitourinary Cancer Treatment-The Effect of Dose-Response on 2D and 3D Cell Cultures.

International journal of molecular sciences, 2021, Nov-04, Volume: 22, Issue:21

Topics: Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Cell Culture Techniques, Three Dimensional; Cell Cycle; Cell Proliferation; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Levofloxacin; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Urogenital Neoplasms

2021